Medication info

MDapa Tablet 5 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Macknoty Pharmaceutical Co., Ltd.
Appearance
Yellow, round, biconvex, film-coated tablet
Packaging
PTP - 28 tablets/box [28 tablets (7 tablets/PTP x 4)], bottle - 30 tablets/bottle
Approval status
Active

MFDS item code 202204688 · Approved 2022.12.29

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug treatment who are receiving this medicine in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Macknoty Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • abnormal blood sugar regulation
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medicine is used as an adjunct to dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be administered alone, and may also be used in combination with other medications as needed. It is particularly important to refer to the guidance of a specialist and clinical trial information before use in patients with cardiovascular disease or risk factors whose blood sugar is not adequately controlled. This medication helps to improve blood sugar control and assists in diabetes management.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug treatment who are receiving this medicine in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be administered to certain patients. For example, individuals with allergies to the active ingredients or excipients, patients with type 1 diabetes, those with diabetic ketoacidosis, and patients with lactose intolerance or related genetic issues should not take this medication. Also, patients undergoing dialysis should avoid using this medication. Patients with a reduced fluid volume or impaired kidney function should use this medication with caution as it may lower blood pressure or cause temporary changes in kidney function. Especially, patients with moderate to severe renal impairment or elderly patients, or individuals taking diuretics should be thoroughly evaluated for fluid status and kidney function before administering this medication, and periodic checks for symptoms of hypotension or kidney function should be performed after administration. When taking this medication, infections such as genital infections and urinary tract infections may occur, so if symptoms of infection manifest, consult a doctor immediately. Additionally, hypoglycemia may occur, so particularly for patients taking insulin or sulfonylureas, it may be necessary to adjust the medication dosage to reduce the risk of hypoglycemia. Dehydration or symptoms of hypotension may occur due to decreased fluid volume, so if these symptoms arise, consult medical personnel immediately, and temporarily discontinue medication if necessary. This medication can cause severe metabolic acidosis, such as ketoacidosis, so if symptoms like vomiting, abdominal pain, difficulty breathing, or fatigue appear, visit a hospital immediately. Ketoacidosis can occur even if blood sugar is not high, so caution is warranted. Pregnant or breastfeeding women should not take this medication, and if pregnancy is confirmed, the medication should be discontinued immediately. Elderly patients or those with impaired kidney function require special caution when taking this medication, and fluid status and kidney function should be checked frequently. This medication, when taken with other diuretics, may increase the risk of dehydration and hypotension, so caution is advised in such cases. Additionally, when taken with insulin or insulin secretagogues, the risk of hypoglycemia may increase, necessitating possible dosage adjustments. In case of overdose, there are no specific antidotes, so appropriate treatment should be provided based on the patient's condition, and if symptoms are severe, medical attention should be sought immediately. During treatment, caution should be exercised when driving or operating machinery due to the risk of hypoglycemia, and it should be kept out of reach of children.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, vulvar pruritus, genital pruritus, increased hematocrit, decreased creatinine clearance in early treatment, dyslipidemia, elevated blood creatinine in early treatment, elevated blood urea, weight loss, acute pyelonephritis, chest pain, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, paresthesia, cerebral infarction, nerve compression, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, acute pyelonephritis, chest pain, chronic gastritis, diverticulum, pneumoperitoneum, frequent bowel movement, gastroenteritis, colon polyp, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gingival disorder, gingival pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, pressure urinary incontinence, hesitancy, urinary stones, abnormal urination, increased blood lactate, lymphocytopenia, vitamin D deficiency, hyperglycemia, increased appetite, dysgeusia, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, coma, neuralgia, peripheral neuropathy, sleep disorder, syncope, tremor, bronchitis, shingles, sinusitis, tonsillitis, diverticulitis, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like symptoms, chest pain, fatigue, pain, edema, foreign body sensation, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularity, pruritus, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, shortness of breath, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. Proper storage will help retain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Yellow, round, biconvex, film-coated tablet

Package unit

PTP - 28 tablets/box [28 tablets (7 tablets/PTP x 4)], bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.